Education
Positions*
Research work
Performance
2023
-
Hamza S, Martynova E, Garanina E, Shakirova V, Bilalova A, Moiseeva S, Khaertynova I, Ohlopkova O, Blatt N, Markelova M, Khaiboullina S. Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia. Int J Mol Sci. 2023 Jun 15;24(12):10181. doi: 10.3390/ijms241210181. PMID: 37373331; PMCID: PMC10299584.
-
Hamza S, Garanina E.E, Alsaadi M, Blocking the Hormone Receptors Modulates NLRP3 in LPS-Primed Breast Cancer Cells//International Journal of Molecular Sciences. - 2023. - Vol.24, Is.5. - Art. №4846.
2022
-
Martynova E, Hamza S, Markelova M, Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19//Frontiers in Immunology. - 2022. - Vol.13, Is.. - Art. №830715.
-
Garanina E, Hamza S, Stott-Marshall R.J, Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients//Frontiers in Microbiology. - 2022. - Vol.13, Is.. - Art. №842232.
- Hamza S. Prolonged immune response induced by sputnik V vaccine / S. Hamza, E. Martynova, E. Garanina, M. Markelova, V. Shakirova, Y. Davidyuk, V. Lezhnyova, A. Laikov, A. Rizvanov, S. Khaiboullina // EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Special Is.1 - P.121.
- Hamza Shaimaa, Garanina Ekaterina E., Khaiboullina Svetlana F., Tamoxifen suppresses NLRP3 priming via miR-223 in breast cancer independently from ER alpha//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.2-2.
-
Tezcan G, Alsaadi M, Hamza S, Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells//International journal of molecular sciences. - 2022. - Vol.23, Is.16. - .
- Hamza Sh. Antibody immune responses to SARS-CoV-2 peptides in COVID-19 convalescent patients / Sh. Hamza, E.E. Garanina, E.V. Martynova, M.I. Markelova, Y.N. Davidyuk, V.G. Shakirova, S.F. Khaiboullina // Фундаментальные и прикладные исследования по приоритетным направлениям биоэкологии и биотехнологии : сборник материалов V Всерос. науч.-практ. конф. с международным участием (Ульяновск, 20 мая 2022 г.) / гл. ред. Е.И. Антонова; Ульяновский государственный педагогический университет им. И.Н. Ульянова. – Чебоксары: Среда, 2022. – C. 220-226.
- Hamza S, Garanina E, Alsaadi M, Tamoxifen reduces hepatocyte growth factor secretion in breast cancer cells with high NLRP3 expression//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
2021
-
Tezcan G, Garanina E.E, Alsaadi M, Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer//Frontiers in Immunology. - 2021. - Vol.11, Is.. - Art. № 607881.
- Hamza S, Garanina EE, Tezcan G, Trapping miR-223 leads to overexpression of NLRP3 in colorectal cancer//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A126-A126.
-
Martynova E, Hamza S, Garanina E.E, Long term immune response produced by the sputnikv vaccine//International Journal of Molecular Sciences. - 2021. - Vol.22, Is.20. - Art. №11211.
-
Alsaadi M, Tezcan G, Garanina E.E, Doxycycline attenuates cancer cell growth by suppressing nlrp3-mediated inflammation//Pharmaceuticals. - 2021. - Vol.14, Is.9. - Art. №852.
2020
| Work address: | 9 Parizhskoy Kommuny Str., Kazan, Academic and Research Centre of the Institute of Fundamental Medicine and Biology |
| Office number: | 205 |
| Phone: | 89656089705 |
| E-mail: | shaimaa.hamza94@gmail.com |
| Google scholar: | https://scholar.google.com/citations?hl=en&user=Trmtb1IAAAAJ |